{"text": "rt AT_USER #nih #nci $gild $nvs #cancer #pharma #biotech URL"}
{"text": "rt AT_USER most interesting new info in fda $gild car-t approval pr is probably this soon-to-be released comprehensive policy for reg\u00a1\u00ad"}
{"text": "#nih #nci $gild $nvs #cancer #pharma #biotech URL"}
{"text": "commented on URL $celg $juno $nvs $gild"}
{"text": "$gild +2.0% at $81.59, on fda approval news. the daily candle is indecisive. rising trend at $80.50. if fail 72s. m\u00a1\u00ad URL"}
{"text": "the fda approved car-tcr as we forecasted. congrats to patients and shareholders! URL $gild $kite"}
{"text": "thought.....will money flow out of $celg into $gild?..."}
{"text": "subscribe to our 100% free weekly newsletter to get trading tips, picks, charts, &amp; more! URL URL"}
{"text": "a revolutionary treatment could help more than 10,000 people living with largely untreatable cancer $gild\u00a1\u00ad URL"}
{"text": "a revolutionary treatment could help more than 10,000 people living with largely untreatable cancer $gild\u00a1\u00ad URL"}
{"text": "rt AT_USER .AT_USER goes after $gild on $373k price of yescarta. calls on trump &amp; congress to act on drug prices URL"}
{"text": "gild top news - oct 19th, 2017 $gild URL"}
{"text": "rt AT_USER $cyrx client AT_USER (AT_USER receives approval for yescarta to treat non-hodgkin lymphoma. URL"}
{"text": "AT_USER AT_USER $gild has cured 1.5m patients w hep c; 10m patients in sub-saharan africa on $gild hiv drug\u00a1\u00ad URL"}
{"text": "#aidshealthcare calls for $gild to reduce price of tenofovir drugs by up to 90% as #drugpatent nears expiry URL"}
{"text": "$gild drugs make up only 14% of healthcare costs, yet they provide the most material benefit and lessen other healthcare costs"}
{"text": "$gild not to mention this is priced $75k lower than the current standard of care, kymriah from $nvs"}
{"text": "$gild when drugmakers can\u00a1\u00aft charge high prices on rare disease drugs, they don\u00a1\u00aft lower prices, they stop making rar\u00a1\u00ad URL"}
{"text": "AT_USER AT_USER i think it was known.  i thought there would be a bigger pop today.  obviously pricing is a c\u00a1\u00ad URL"}
{"text": "AT_USER i thought we would see a bigger pop on the approval.  mildly concerning.  maybe it was already baked in $gild"}
{"text": "price moves vs expected moves $teva $gild $pfe $agn $jnj $vrx $abbv $abt $immu $celg $mnkd $trxc\u00a1\u00ad URL"}
{"text": "don't miss our next free option trade.  sign up for our daily free trades at URL $nvda $tsla $gs $gild $biib $googl $fb"}
{"text": "$cyrx client AT_USER (AT_USER receives approval for yescarta to treat non-hodgkin lymphoma. URL $kite $gild"}
{"text": "gilead sciences, inc. $gild downgraded by zacks investment research to \u00a1\u00b0sell\u00a1\u00b1 URL"}
{"text": "rt AT_USER most interesting new info in fda $gild car-t approval pr is probably this soon-to-be released comprehensive policy for reg\u00a1\u00ad"}
{"text": "$gild $qqq $biib $ibb held up pretty will today in my view, when everyone was heading for the exits this morning on\u00a1\u00ad URL"}
{"text": "rt AT_USER dear sell-side analysts \u00a1\u00aa \u00a1\u00b0say yes to yescarta\u00a1\u00b1 can no longer be used in your $gild notes. URL"}
{"text": "not just cost of developing yescarta that goes into the price, but also cost of all failures too! $gild ask $celg URL"}
{"text": "AT_USER AT_USER AT_USER $gild gets car t approval and goes up a buck. $celg stops clinical on 1 product and goes down10."}
{"text": "AT_USER AT_USER the cost benefit of $gild's hep c treatment sovaldi was a huge overall savings to the healt\u00a1\u00ad URL"}
{"text": "rt AT_USER most interesting new info in fda $gild car-t approval pr is probably this soon-to-be released comprehensive policy for reg\u00a1\u00ad"}
{"text": "rt AT_USER most interesting new info in fda $gild car-t approval pr is probably this soon-to-be released comprehensive policy for reg\u00a1\u00ad"}
{"text": "rt AT_USER on the other hand, probably gives $glpg - $gild combo a leg up...consensus had mongersen rev in 2020 at ~$432 million"}
{"text": "rt AT_USER most interesting new info in fda $gild car-t approval pr is probably this soon-to-be released comprehensive policy for reg\u00a1\u00ad"}
{"text": "rt AT_USER most interesting new info in fda $gild car-t approval pr is probably this soon-to-be released comprehensive policy for reg\u00a1\u00ad"}
{"text": "rt AT_USER .AT_USER goes after $gild on $373k price of yescarta. calls on trump &amp; congress to act on drug prices URL"}
{"text": "rt AT_USER $gild is set to break 50dma, and cool toward prime target of the 71/72s. m/t bullish to $110. f' pe 10s is crazy! yield 2\u00a1\u00ad"}
{"text": "maxim group reaffirms \u00a1\u00b0hold\u00a1\u00b1 rating for gilead sciences, inc. $gild URL"}
{"text": "rt AT_USER most interesting new info in fda $gild car-t approval pr is probably this soon-to-be released comprehensive policy for reg\u00a1\u00ad"}
{"text": "rt AT_USER .AT_USER goes after $gild on $373k price of yescarta. calls on trump &amp; congress to act on drug prices URL"}
{"text": "$jnj, tiny #rna #biotech #arcturus combine for #hepatitisb work #hepb #hepatitis #hepc #pharma $gild URL"}
{"text": ".AT_USER goes after $gild on $373k price of yescarta. calls on trump &amp; congress to act on drug prices URL"}
{"text": "AT_USER asks what good does a breakthrough medication do if no one can afford it? re $gild car-t pricing"}
{"text": "in other words, long $gild. URL"}
{"text": "on the other hand, probably gives $glpg - $gild combo a leg up...consensus had mongersen rev in 2020 at ~$432 million"}
{"text": "$celg the analyst that down graded the stk 15 points ago now doesn't look so bad.  $celg finds themselves in a position like $biib $gild"}
{"text": "rt AT_USER most interesting new info in fda $gild car-t approval pr is probably this soon-to-be released comprehensive policy for reg\u00a1\u00ad"}
{"text": "commented on URL $adms $agn $flxn $gild $kite $neos $nvs $pgnx $rxdx $sppi $vray"}
{"text": "commented on URL $adms $agn $flxn $gild $kite $neos $nvs $pgnx $rxdx $sppi $vray"}
{"text": "commented on URL $adms $agn $flxn $gild $kite $neos $nvs $pgnx $rxdx $sppi $vray"}
{"text": "$gild calls closed .15 last (my avg is .14)."}
{"text": "URL $adms $agn $flxn $gild $kite $neos $nvs $pgnx $rxdx $sppi $vray"}
{"text": "rt AT_USER today action start day assuming $2.4k #loss on $tsla... thanks $gild $googl $spx $axp $ulta AT_USER for giving $1\u00a1\u00ad"}
{"text": "$gild lots of high paying jobs with this yescarter. trump gov will love this one. eol costs $197,000, so cost is not the issue as far as hos"}
{"text": "maxim group reaffirms \u00a1\u00b0hold\u00a1\u00b1 rating for gilead sciences, inc. $gild URL"}
{"text": "rt AT_USER most interesting new info in fda $gild car-t approval pr is probably this soon-to-be released comprehensive policy for reg\u00a1\u00ad"}
{"text": "maxim group reaffirms \u00a1\u00b0hold\u00a1\u00b1 rating for gilead sciences, inc. $gild URL"}
{"text": "contrasting gilead sciences $gild &amp; its rivals URL"}
{"text": "contrasting gilead sciences $gild &amp; its rivals URL"}
{"text": "contrasting gilead sciences $gild &amp; its rivals URL"}
{"text": "contrasting gilead sciences $gild &amp; its rivals URL #acn"}
{"text": "contrasting gilead sciences $gild &amp; its rivals URL"}
{"text": "rt AT_USER most interesting new info in fda $gild car-t approval pr is probably this soon-to-be released comprehensive policy for reg\u00a1\u00ad"}
{"text": "URL $adms $agn $flxn $gild $kite $neos $nvs $pgnx $rxdx $sppi $vray"}
{"text": "didn't do so well today...over traded, revenge traded, and used too much size.  all broken rules.  ($3200) $ebay $gild"}
{"text": "gilead sciences's hold rating reiterated at maxim group. URL $gild #gild"}
{"text": "gilead sciences's hold rating reiterated at maxim group. URL $gild #gild"}
{"text": "don't miss our next free option trade.  sign up for our daily free trades at URL $nvda $tsla $gs $gild $mu $googl $fb"}
{"text": "just added $gild to the portfolio"}
{"text": "rt AT_USER $gild (kite) followed $nvs with their own cancer drug approval today. + $nwbo ph3 brain cancer readout will attract big pha\u00a1\u00ad"}
{"text": "rt AT_USER today action start day assuming $2.4k #loss on $tsla... thanks $gild $googl $spx $axp $ulta AT_USER for giving $1\u00a1\u00ad"}
{"text": "rt AT_USER $gild looks like dip buyers will be rewarded with bounce from 50-ma on fda approval $kite URL"}
{"text": "rt AT_USER $gild (kite) followed $nvs with their own cancer drug approval today. + $nwbo ph3 brain cancer readout will attract big pha\u00a1\u00ad"}
{"text": "another win 4m $gild in fight against #cancer but drug price $373,000 #shocking that it is cheaper than $nvs #health URL"}
{"text": "today action start day assuming $2.4k #loss on $tsla... thanks $gild $googl $spx $axp $ulta AT_USER for gi\u00a1\u00ad URL"}
{"text": "$eigr train back on track low mv, promising pipeline. #biotech $gild $biib $celg $amgn $ions $once $spark $espr $kite $juno $halo $ibb $srpt"}
{"text": "rt AT_USER fda doubles down on \"gene therapy\" language in approving $gild car-t yescarta: URL"}
{"text": "$gild added"}
{"text": "$gild an example how #whoknows AT_USER from tuesday entries call 80 were dead and today beauty surprise...\u00a1\u00ad URL"}
{"text": "keep tabs on what's moving each day by following us $immy $adhd $crbp $blfs $adbe $gild $imnp $optt $dxtr $ebay $pm URL"}
{"text": "rt AT_USER $gild gets fda approval for car-t cell based gene therapy, shares moving up $2.20 in the pre"}
{"text": "analysts at cowen &amp; co. didn't change their \"buy\" rating for gilead sciences $gild with $90.0 price target ..."}
{"text": "rt AT_USER $gild not the bad guy, took a $12b risk, need to recoup that + roi...or else innovation will come to a halt, why do pe\u00a1\u00ad"}
{"text": "fda approves breakthrough cancer treatment $gild  URL"}
{"text": "gilead sciences\u00a1\u00af $gild buy rating reaffirmed at william blair URL"}
{"text": "gilead sciences\u00a1\u00af $gild buy rating reaffirmed at william blair URL"}
{"text": "gilead sciences, inc. $gild price target raised to $85.00 at leerink swann URL"}
{"text": "rt AT_USER bmo interested to see how $gild will leverage its new oncology platform synergy of car-t therapy with ... #gene #editi\u00a1\u00ad"}
{"text": "rt AT_USER rbc says: $gild $kite \"the start of a potential large oncology franchise, ripe for #additional #complementary #acquisi\u00a1\u00ad"}
{"text": "rt AT_USER most interesting new info in fda $gild car-t approval pr is probably this soon-to-be released comprehensive policy for reg\u00a1\u00ad"}
{"text": "rt AT_USER most interesting new info in fda $gild car-t approval pr is probably this soon-to-be released comprehensive policy for reg\u00a1\u00ad"}
{"text": "AT_USER $gild kissed top rail of a falling wedge and came in.  watch for a pull.  go time soon imo"}
{"text": "$gild bounce on daily chart URL"}
{"text": "rt AT_USER we discuss $gild car-t approval, up next on AT_USER"}
{"text": "we discuss $gild car-t approval, up next on AT_USER"}
{"text": "don't miss our next free option trade.  sign up for our daily free trades at URL $nvda $tsla $gs $gild $amd $googl $fb"}
{"text": "rt AT_USER slight change to zuma-1 remission data in yescarta label (independent review) vs #aacr17 (investigator-assessed) $kite $gi\u00a1\u00ad"}
{"text": "gilead's yescarta cancer treatment approved, some analysts shrug URL $gild $juno $nvs  via AT_USER"}
{"text": "gilead sciences $gild share value declined while kcm investment advisors decreased position by $308,000 ..."}
{"text": "rt AT_USER 35 stocks moving in thursday's mid-day session URL $immy $adhd $qure $crbp $blfs $adbe $gild $imnp $optt\u00a1\u00ad"}
